Types and Rates of Major Adverse Cardiovascular Events in Antithrombotic Trials: A Systematic Review and Meta-Analysis

Major adverse cardiovascular events (MACE) are common composite end points in trials of antithrombotic therapies, yet their definitions and component event rates may vary between cardiovascular disease and stroke populations. We compared definitions and annualized rates of MACE components, bleeding...

Celý popis

Podrobná bibliografia

Vydané v:	Canadian journal of cardiology
Hlavní autori:	Wang, Yundi, Fuerte-Hortigon, Alejandro, Chetty, Sarvani, Garah, Mays, Sarmiento, Robert, Barber, Philip A., Saposnik, Gustavo, Lee, Douglas S., Singnurkar, Amit, Swartz, Richard H., Varickanickal, Joann, Field, Thalia S.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Elsevier Inc 25.10.2025
Predmet:	antithrombotics Cardiovascular major adverse cardiovascular events prevention stroke major adverse cardiovascular events cardiovascular stroke prevention antithrombotics
ISSN:	0828-282X, 1916-7075, 1916-7075
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!